Brambilla A - Search Results

1

Medicinal chemistry of muscarinic agonists for the treatment of dementia disorders.

Cereda E, Brambilla A, Ezhaya A, Gaida W, Mendla K, Monferini E, Pitsikas N, Schiavi GB, Sagrada A. Cereda E, et al. Among authors: brambilla a. Eur J Drug Metab Pharmacokinet. 1994 Jul-Sep;19(3):179-83. doi: 10.1007/BF03188919. Eur J Drug Metab Pharmacokinet. 1994. PMID: 7867659

2

Synthesis and biological evaluation of new antimuscarinic compounds with amidine basic centers. A useful bioisosteric replacement of classical cationic heads.

Cereda E, Ezhaya A, Gil Quintero M, Bellora E, Dubini E, Micheletti R, Schiavone A, Brambilla A, Schiavi GB, Donetti A. Cereda E, et al. Among authors: brambilla a. J Med Chem. 1990 Aug;33(8):2108-13. doi: 10.1021/jm00170a010. J Med Chem. 1990. PMID: 2374141

3

DAU 6215, a novel 5-HT3-receptor antagonist, selectively antagonizes scopolamine-induced deficit in a passive-avoidance task, but not scopolamine-induced hypermotility in rats.

Brambilla A, Ghiorzi A, Pitsikas N, Borsini F. Brambilla A, et al. J Pharm Pharmacol. 1993 Sep;45(9):841-3. doi: 10.1111/j.2042-7158.1993.tb05698.x. J Pharm Pharmacol. 1993. PMID: 7903377

4

Effect of DAU 6215, a novel 5-HT3 receptor antagonist, on scopolamine-induced amnesia in the rat in a spatial learning task.

Pitsikas N, Brambilla A, Borsini F. Pitsikas N, et al. Among authors: brambilla a. Pharmacol Biochem Behav. 1994 Jan;47(1):95-9. doi: 10.1016/0091-3057(94)90116-3. Pharmacol Biochem Behav. 1994. PMID: 8115433

5

DAU 6215, a novel 5-HT3 receptor antagonist, improves performance in the aged rat in the Morris water maze task.

Pitsikas N, Brambilla A, Borsini F. Pitsikas N, et al. Among authors: brambilla a. Neurobiol Aging. 1993 Nov-Dec;14(6):561-4. doi: 10.1016/0197-4580(93)90039-e. Neurobiol Aging. 1993. PMID: 8295658

6

Behavioral effects of flibanserin (BIMT 17).

Borsini F, Brambilla A, Grippa N, Pitsikas N. Borsini F, et al. Among authors: brambilla a. Pharmacol Biochem Behav. 1999 Sep;64(1):137-46. doi: 10.1016/s0091-3057(99)00072-6. Pharmacol Biochem Behav. 1999. PMID: 10495008

7

BIIR 561 CL: a novel combined antagonist of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors and voltage-dependent sodium channels with anticonvulsive and neuroprotective properties.

Weiser T, Brenner M, Palluk R, Bechtel WD, Ceci A, Brambilla A, Ensinger HA, Sagrada A, Wienrich M. Weiser T, et al. Among authors: brambilla a. J Pharmacol Exp Ther. 1999 Jun;289(3):1343-9. J Pharmacol Exp Ther. 1999. PMID: 10336525

8

A model for studying saliva secretion in the conscious dog.

Pagani F, Sagrada A, Brambilla A, Brunet S, Giachetti A. Pagani F, et al. Among authors: brambilla a. Arch Int Pharmacodyn Ther. 1988 Jan-Feb;291:253-62. Arch Int Pharmacodyn Ther. 1988. PMID: 3365065

9

Effects of cerestat and NBQX on functional and morphological outcomes in rat focal cerebral ischemia.

Pitsikas N, Brambilla A, Besozzi C, Bonali P, Fodritto F, Grippa N, Scandroglio A, Borsini F. Pitsikas N, et al. Among authors: brambilla a. Pharmacol Biochem Behav. 2001 Mar;68(3):443-7. doi: 10.1016/s0091-3057(00)00469-x. Pharmacol Biochem Behav. 2001. PMID: 11325397

10

Pharmacological profile of mifentidine: a novel H2-receptor antagonist.

Giachetti A, Pagani F, Micheletti R, Brambilla A, Cereda E, Donetti A. Giachetti A, et al. Among authors: brambilla a. Agents Actions. 1985 Apr;16(3-4):173-5. doi: 10.1007/BF01983131. Agents Actions. 1985. PMID: 2861730

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

238 results

Search Page

Filters